Mono Pharmacare (MONOPHARMA) Shareholding Pattern

NSE: MONOPHARMA • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 56.72%
FII Holding 0.00%
DII Holding 0.00%
Public Holding 34.48%
Total Shareholders 514
As of Sept 2025
View the latest shareholding pattern of Mono Pharmacare (MONOPHARMA) including promoter, FII, DII, and public holdings. Track MONOPHARMA ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See MONOPHARMA enterprise value)

Mono Pharmacare (MONOPHARMA) Shareholding Summary

  • Promoter holding remains unchanged at 56.72% in Sept 2025
  • FII/FPI holding remains unchanged at 0.00% in Sept 2025
  • DII holding remains unchanged at 0.00% in Sept 2025
  • Public holding has decreased from 35.60% to 34.48% in Sept 2025
  • Number of shareholders increased from 478 to 514 in Sept 2025

MONOPHARMA Quarterly Ownership Changes

Quarter-over-quarter changes for Mono Pharmacare from Mar 2025 to Sept 2025.

Promoter Holding Change
Mar 2025 to Sept 2025
No Change
FII Holding Change
Mar 2025 to Sept 2025
No Change
DII Holding Change
Mar 2025 to Sept 2025
No Change
Public Holding Change
Mar 2025 to Sept 2025
-1.12%

Mono Pharmacare (MONOPHARMA) Quarterly Shareholding Trends

Visual breakdown of MONOPHARMA ownership distribution over time. Learn more about Mono Pharmacare yearly highs lows.

Promoter
FII
DII
Public
Government

Rising institutional holdings in MONOPHARMA often correlate with improved fundamentals. Check out Mono Pharmacare price earnings.

Mono Pharmacare (MONOPHARMA) Shareholding Data

Download complete MONOPHARMA ownership data for offline analysis. Discover Mono Pharmacare dividend policy.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 56.72% 0.00% 0.00% 0.00% 34.48% 8.80% 100.00% 514
Mar 2025 56.72% 0.00% 0.00% 0.00% 35.60% 7.68% 100.00% 478
Sept 2024 56.72% 0.00% 0.00% 0.00% 35.27% 8.01% 100.00% 463
Mar 2024 56.72% 0.00% 0.00% 0.00% 36.69% 6.59% 100.00% 418
Dec 2023 56.72% 0.00% 0.00% 0.00% 37.21% 6.07% 100.00% 528
Sept 2023 56.72% 0.00% 0.00% 0.00% 38.13% 5.14% 99.99% 972
Aug 2023 81.03% 0.00% 0.00% 0.00% 0.00% 18.97% 100.00% 17
Apr 2023 81.03% 0.00% 0.00% 0.00% 0.00% 18.97% 100.00% 17

MONOPHARMA promoter holding above 50% indicates strong insider confidence. Explore the MONOPHARMA income statement for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Sept 2025 56.72% 0.00% 0.00% 0.00% 34.48% 8.80% 100.00% 514
Mar 2025 56.72% 0.00% 0.00% 0.00% 35.60% 7.68% 100.00% 478
Sept 2024 56.72% 0.00% 0.00% 0.00% 35.27% 8.01% 100.00% 463
Mar 2024 56.72% 0.00% 0.00% 0.00% 36.69% 6.59% 100.00% 418
Dec 2023 56.72% 0.00% 0.00% 0.00% 37.21% 6.07% 100.00% 528
Sept 2023 56.72% 0.00% 0.00% 0.00% 38.13% 5.14% 99.99% 972
Aug 2023 81.03% 0.00% 0.00% 0.00% 0.00% 18.97% 100.00% 17
Apr 2023 81.03% 0.00% 0.00% 0.00% 0.00% 18.97% 100.00% 17

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2025 56.72% 0.00% 0.00% 0.00% 35.60% 7.68% 100.00% 478
Mar 2024 56.72% 0.00% 0.00% 0.00% 36.69% 6.59% 100.00% 418
Dec 2023 56.72% 0.00% 0.00% 0.00% 37.21% 6.07% 100.00% 528

Year-over-year trends reveal long-term ownership shifts.

Understanding Mono Pharmacare (MONOPHARMA) Shareholding Pattern

Mono Pharmacare shareholding pattern reveals who owns MONOPHARMA stock and how ownership changes over time. High promoter stakes in MONOPHARMA often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your MONOPHARMA trades. MONOPHARMA DCF

Combine MONOPHARMA ownership analysis with price movements and financial performance for a complete investment picture. (See MONOPHARMA true value)